This bill aims to enhance oversight and accountability of the 340B Drug Pricing Program in Minnesota by authorizing independent audits of 340B covered entities conducted by nonprofit public interest organizations. It introduces a new definition for "nonprofit public interest organization," which excludes 340B covered entities and their affiliates, ensuring that audits are performed by independent entities experienced in financial or legal review. The bill mandates that 340B covered entities must cooperate with these audits by providing necessary data and information, while also ensuring that the nonprofit organizations maintain confidentiality regarding the information obtained during the audit process.

Additionally, the bill requires that 340B covered entities allocate at least 25 percent of their net revenue from the 340B program towards charity care, explicitly stating that medical debt write-offs and community service do not count towards this requirement. The enforcement of this provision is not only the responsibility of the commissioner but also includes the attorney general, thereby strengthening the enforcement mechanisms in place. Overall, the bill seeks to ensure that the benefits of the 340B program are directed towards charitable healthcare services in Minnesota.

Statutes affected:
Introduction: 62J.461